14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
MTVA vs STTK: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Shattuck Labs, Inc. (STTK) is the stronger overall head-to-head candidate over MetaVia Inc. (MTVA) in the Tradestie Institutional Equity Comparison Engine, winning 5–1 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Options & Positioning). MTVA carries a Unified Composite Score of 48.0/100 (HOLD) at $1.01 (N/M Forward P/E, 0.0% operating margin), whereas STTK carries 61.7/100 (BUY) at $4.46 (N/M Forward P/E, 0.0% operating margin).
Growth vs. Quality Trade-Off: STTK earns the overall head-to-head edge with a stronger Unified Composite Score (61.7/100 BUY vs. MTVA 48.0/100 HOLD) and 1.41β · 68% Vol risk profile, whereas MTVA leads top-line expansion (+0.0% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: MTVA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.1); meanwhile STTK is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MTVA vs STTK. Trailing 12-month operating profitability (MTVA 0.0% vs STTK 0.0%) and valuation multiples (MTVA N/M vs STTK N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Biotechnology value chain with $459.3M market capitalization and 0.0% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ MTVA vs STTK Key Questions & Quantitative Answers
As of Nov 20, 2026, Shattuck Labs, Inc. (STTK) is the stronger overall head-to-head candidate over MetaVia Inc. (MTVA) in the Tradestie Institutional Equity Comparison Engine, winning 5–1 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Options & Positioning). MTVA carries a Unified Composite Score of 48.0/100 (HOLD) at $1.01 (N/M Forward P/E, 0.0% operating margin), whereas STTK carries 61.7/100 (BUY) at $4.46 (N/M Forward P/E, 0.0% operating margin). Growth vs. Quality Trade-Off: STTK earns the overall head-to-head edge with a stronger Unified Composite Score (61.7/100 BUY vs. MTVA 48.0/100 HOLD) and 1.41β · 68% Vol risk profile, whereas MTVA leads top-line expansion (+0.0% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: MTVA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.1); meanwhile STTK is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
MTVA leads the Growth & Scale pillar: MTVA posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with STTK at -66.6% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, MTVA generates N/A in USD-normalized revenue versus N/A for STTK. In operating R&D and SG&A reinvestment, MTVA deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for STTK.
MTVA and STTK trade at balanced relative valuation multiples. MTVA trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin), whereas STTK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MTVA (-175.7% ROE) versus STTK (-47.2% ROE) capital efficiency.
In options market volatility and institutional positioning, MTVA carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.30β · 166% Vol realized risk). By comparison, STTK carries 72.4% implied volatility (10th %ile, Compressed (<25th %ile)), a 4.66x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (1.41β · 68% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.